Viatris Inc (VTRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Viatris Inc Stock (VTRS) Company Profile

Healthcare (1146)

(724) 514-1465

1000 MYLAN BOULEVARD, CANONSBURG

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VTRS's Discussions on Twitter

Vergleichen Sie VTRS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VTRS Viatris Inc	9.925	11.50B	14.33B	-3.79B	1.84B	-3.17
ZTS Zoetis Inc	143.04	63.05B	9.39B	2.62B	2.22B	5.8121
TAK Takeda Pharmaceutical Co Adr	13.77	43.33B	29.96B	957.25M	4.77B	0.2956
HLN Haleon Plc Adr	9.15	40.43B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	20.07	22.97B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	433.01	19.90B	3.08B	1.24B	1.07B	25.61

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-06	Eingeleitet	Goldman	Neutral
2024-07-19	Fortgesetzt	Jefferies	Buy
2023-10-23	Herabstufung	BofA Securities	Neutral → Underperform
2023-06-23	Herabstufung	Barclays	Equal Weight → Underweight
2023-04-24	Herabstufung	Barclays	Overweight → Equal Weight
2023-02-17	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2023-01-27	Hochstufung	Jefferies	Hold → Buy
2022-11-10	Hochstufung	UBS	Sell → Neutral
2022-11-08	Hochstufung	Piper Sandler	Underweight → Neutral
2022-10-21	Fortgesetzt	Jefferies	Hold
2022-06-14	Eingeleitet	UBS	Sell
2022-05-10	Herabstufung	Piper Sandler	Neutral → Underweight
2022-03-01	Herabstufung	BofA Securities	Buy → Neutral
2022-03-01	Herabstufung	Raymond James	Outperform → Mkt Perform
2021-06-15	Eingeleitet	Citigroup	Neutral
2021-04-07	Fortgesetzt	RBC Capital Mkts	Outperform
2021-03-08	Herabstufung	Goldman	Buy → Neutral
2021-03-02	Herabstufung	JP Morgan	Overweight → Neutral
2021-02-26	Herabstufung	Wolfe Research	Outperform → Peer Perform
2021-01-05	Eingeleitet	Argus	Hold
2020-12-14	Eingeleitet	Bernstein	Mkt Perform

Alle ansehen

Viatris Inc Aktie (VTRS) Neueste Nachrichten

Finanzdaten der Viatris Inc-Aktie (VTRS)

Viatris Inc (VTRS)

Viatris Inc Stock (VTRS) Company Profile

Vergleichen Sie VTRS mit anderen Aktien

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Viatris Inc Aktie (VTRS) Neueste Nachrichten

Will Viatris Inc. stock benefit from upcoming earnings reportsMarket Performance Summary & Weekly High Conviction Ideas - newser.com

Is Viatris Inc. stock a good choice for value investorsJuly 2025 Sentiment & Community Verified Trade Alerts - newser.com

Can trapped investors hope for a rebound in Viatris Inc.Market Movement Recap & Step-by-Step Trade Execution Guides - newser.com

Pattern recognition hints at Viatris Inc. upsideJuly 2025 Market Mood & Proven Capital Preservation Methods - newser.com

Nov 11 & 18: Viatris Fireside Chats at UBS and Jefferies — Live webcasts and archived access - Stock Titan

Viatris Inc. (VTRS) Stock Analysis: Exploring a 17.34% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews

Developing predictive dashboards with Viatris Inc. data2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com

Viatris Inc. Stock Falls Friday, Still Outperforms Market - 富途牛牛

Kotak Alts-backed Matrix Pharma buys bulk-drugs maker - VCCircle

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga

5th Year on Forbes' World's Best Employers: Viatris Named to 2025 List After 300,000-Respondent Survey - Stock Titan

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row - The Malaysian Reserve

Viatris shares break six-session winning streak - MSN

Viatris Inc. (VTRS) Investor Outlook: Navigating a 12.15% Potential Upside Amidst Healthcare Challenges - DirectorsTalk Interviews

What analysts say about Viatris Inc stockRSI Overbought/Oversold & Small Entry Cost Trading - earlytimes.in

Morocco fines Viatris 7.58 million dirhams over Mylan-Pfizer merger - MSN

Allergy Treatment Global Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, ALK - PharmiWeb.com

Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025 - BioSpace

The Importance of a Global, Resilient Supply Chain to Access - CSRwire

Relative strength of Viatris Inc. in sector analysisProduct Launch & Reliable Price Action Trade Plans - newser.com

Acute Social Anxiety Disorder Market on Track for Major Expansion by 2034, According to DelveInsight | GlaxoSmithKline Plc, Viatris Inc, Johnson & Johnson, Novartis AG, Pfizer Inc, AstraZeneca Plc - Barchart.com

Pharmaceutical Giant Viatris Schedules Q3 2025 Financial Results and Investor Conference Call for November 6 - Stock Titan

Will Viatris Inc. stock continue dividend increasesMarket Performance Summary & Risk Controlled Swing Alerts - newser.com

Viatris Inc. (VTRS) Stock Analysis: Exploring a Potential 20% Upside Amid High Dividend Yield - DirectorsTalk Interviews

Quantitative breakdown of Viatris Inc. recent moveJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com

Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineVTRS - 2822news.com

What drives Viatris Inc stock priceBear Market Strategies & Free Unstoppable Trading Performance - earlytimes.in

What drives Viatris Inc VIA stock priceStock Buyback Updates & Build Wealth With Expert Timing Advice - earlytimes.in

What analysts say about Viatris Inc VIA stockCandlestick Trading Patterns & Identify Breakout Stocks - earlytimes.in

Viatris Inc VIA Stock Analysis and ForecastFederal Reserve Announcements & Explosive Profit Growth - Early Times

Is Viatris Stock Underperforming the Nasdaq? - MSN

Viatris: Indore Plant Could Boost 2026 Numbers (NASDAQ:VTRS) - Seeking Alpha

Viatris Nixes Biogen's Extra 1-Year Protection Over MS Drug - Law360

Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection - Insider Monkey

How Viatris’ (VTRS) Removal from the FTSE All-World Index Could Affect Investor Sentiment - Sahm

Viatris Inc.(NasdaqGS: VTRS) dropped from FTSE All-World Index - MarketScreener

Viatris (VTRS): Evaluating Valuation Following FDA Nod for Generic Iron Sucrose and Pipeline Progress - Sahm

Street Watch: Is Viatris Inc a defensive stock2025 Technical Patterns & Weekly Stock Performance Updates - خودرو بانک

Fundamentals Check: Is now the right time to enter Viatris IncJuly 2025 Spike Watch & Target Return Focused Picks - khodrobank.com

Will Viatris Inc. see short term momentum2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com

Trading Recap: Can Viatris Inc. withstand a market correctionInsider Selling & Precise Trade Entry Recommendations - khodrobank.com

Forecast Cut: How do insiders feel about Viatris IncWeekly Stock Report & Long Hold Capital Preservation Tips - خودرو بانک

Short Covering: Will Viatris Inc stock hit new highs in YEAROil Prices & Free Verified High Yield Trade Plans - khodrobank.com

Viatris pulls generic for Teva’s Trisenox in EU - MSN

VIX Spike: Can Viatris Inc ride the EV waveRisk Management & Reliable Momentum Entry Alerts - خودرو بانک

Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light - MSN

Viatris (VTRS) Recovers Slightly But Struggles Amid Market Conce - GuruFocus

Viatris rises after a steep seven-day slide - MSN

Day 7 of Loss Streak for Viatris Stock with -9% Return (vs. -20% YTD) [9/16/2025] - Trefis

Institution Moves: Can Viatris Inc ride the EV waveLong Setup & Daily Momentum Trading Reports - خودرو بانک

Finanzdaten der Viatris Inc-Aktie (VTRS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie VTRS